Holen Sie sich die Stockscreener-App
31.37
1.26%
-0.40
Vorhandelsmarkt:
32.05
0.68
+2.17%
Anaptysbio Inc Aktie (ANAB) Neueste Nachrichten
Is AnaptysBio Inc. stock positioned well for digital economyQuarterly Portfolio Report & Expert Approved Momentum Ideas - newser.com
How AnaptysBio Inc. stock reacts to job market dataJuly 2025 Selloffs & AI Forecast for Swing Trade Picks - newser.com
Should you wait for a breakout in AnaptysBio Inc.Gap Up & High Accuracy Investment Entry Signals - newser.com
AnaptysBio Inc. stock prediction for this weekPortfolio Risk Summary & Technical Pattern Alert System - newser.com
How moving averages guide AnaptysBio Inc. tradingGold Moves & Risk Managed Investment Signals - newser.com
Q3 EPS Estimates for AnaptysBio Lifted by Leerink Partnrs - MarketBeat
Can AnaptysBio Inc. (AN6) stock resist broad market declinesWeekly Stock Recap & Reliable Intraday Trade Alerts - newser.com
Will AnaptysBio Inc. (AN6) stock outperform benchmarks2025 Top Decliners & Free Verified High Yield Trade Plans - newser.com
AnaptysBio splits operations into two companies - MSN
Why AnaptysBio Inc. stock could outperform in 20252025 Institutional Moves & AI Powered Market Trend Analysis - newser.com
AnaptysBio's (ANAB) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
AnaptysBio, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
AnaptysBio, Inc. (NASDAQ:ANAB) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
HighMark Wealth Management LLC Raises Stock Position in AnaptysBio, Inc. $ANAB - MarketBeat
Leerink Partnrs Decreases Earnings Estimates for AnaptysBio - MarketBeat
Custom strategy builders for tracking AnaptysBio Inc.Market Sentiment Report & Growth Focused Stock Reports - newser.com
Is AnaptysBio Inc. reversing from oversold territoryWeekly Trade Review & Daily Chart Pattern Signals - newser.com
Applying sector rotation models to AnaptysBio Inc.2025 Bull vs Bear & Reliable Price Breakout Signals - newser.com
Chart overlay techniques for tracking AnaptysBio Inc.July 2025 Short Interest & Safe Capital Growth Stock Tips - newser.com
Is AnaptysBio Inc. (AN6) stock good for long term investingEarnings Miss & Breakout Confirmation Alerts - newser.com
AnaptysBio (NASDAQ:ANAB) Stock Price Down 5.9%Time to Sell? - MarketBeat
HC Wainwright Analysts Cut Earnings Estimates for AnaptysBio - MarketBeat
Biggest stock movers today: UUUU, FLY, and more - MSN
AnaptysBio (NASDAQ:ANAB) Trading 8.9% Higher After Analyst Upgrade - Defense World
AnaptysBio, Inc. Experiences Revision in Stock Evaluation Amid Market Volatility - Markets Mojo
AnaptysBio (NASDAQ:ANAB) Shares Up 8.9% on Analyst Upgrade - MarketBeat
AnaptysBio Charts Path To Split Into Two Public Companies By 2026 - Sahm
AnaptysBio (NASDAQ:ANAB) Price Target Raised to $59.00 at HC Wainwright - Defense World
AnaptysBio (NASDAQ:ANAB) Shares Gap Up on Analyst Upgrade - Defense World
A house dividing: Anaptysbio wants separate pipeline, royalty firms - BioWorld MedTech
AnaptysBio Announces Business Separation Plans - The Globe and Mail
AnaptysBio Stock Rise: Analyzing Latest Developments - timothysykes.com
AnaptysBio Split Will Establish Separate Royalty And Biopharma Firms - insights.citeline.com
Biggest stock movers Tuesday: WOLF, UUUU, FLY, and more - MSN
AnaptysBio climbs after Leernik raises PT on investor-friendly spinoff plans - TradingView
AnaptysBio Stock Gets A Price Target Hike After Announcing Plan To Separate Royalty, Biopharma Businesses – Check Out The New Level - Stocktwits
J.P. Morgan Maintains AnaptysBio(ANAB.US) With Buy Rating - 富途牛牛
AnaptysBio rises on plans to split company - The Pharma Letter
AnaptysBio stock price target raised to $37 from $32 at Leerink Partners - Investing.com Canada
AnaptysBio's Split Announcement Seems 'Awkward' Amid Clinical Activities, Truist Securities Says - MarketScreener
United Natural Foods Posts Upbeat Results, Joins AnaptysBio, Semtech, UiPath And Other Big Stocks Moving Higher On Tuesday - Benzinga
AnaptysBio (NASDAQ:ANAB) Shares Gap Up Following Analyst Upgrade - MarketBeat
Guggenheim Maintains AnaptysBio(ANAB.US) With Buy Rating, Maintains Target Price $90 - 富途牛牛
Wedbush Reiterates Outperform Rating on AnaptysBio (ANAB) with $45 Target | ANAB Stock News - GuruFocus
A Quick Look at Today's Ratings for AnaptysBio(ANAB.US), With a Forecast Between $57 to $59 - 富途牛牛
ANAB: HC Wainwright & Co. Raises Price Target to $59, Maintains Buy Rating | ANAB Stock News - GuruFocus
Wedbush Reiterates "Outperform" Rating for AnaptysBio (NASDAQ:ANAB) - MarketBeat
AnaptysBio stock price target raised to $59 from $38 at H.C. Wainwright - Investing.com Canada
5.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):